<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04262128</url>
  </required_header>
  <id_info>
    <org_study_id>19-2758</org_study_id>
    <nct_id>NCT04262128</nct_id>
  </id_info>
  <brief_title>Sedentary Behavior in Older Women With and Without Type 2 Diabetes</brief_title>
  <acronym>SitWise</acronym>
  <official_title>Prolonged Sedentary Behavior in Older Women With and Without Type 2 Diabetes: Knowledge, Engagement, and Relationship to Cardiometabolic Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sedentary behavior has been linked to cardiovascular morbidity and mortality, and is&#xD;
      particularly common in older adults with type 2 diabetes. The purpose of this observational,&#xD;
      mixed-methods study is to better understand the relationship between prolonged sedentary&#xD;
      behavior and cardiovascular and metabolic health in older women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will recruit 20 women age 60-75 years, n=10 with uncomplicated type 2&#xD;
      diabetes (T2D) and n=10 healthy controls. Participants will wear two accelerometers and a&#xD;
      continuous glucose monitor (CGM) for two different periods of 7 days for objective assessment&#xD;
      of physical activity, sedentary behavior, and blood glucose, respectively, and complete a&#xD;
      graded exercise test (cardiorespiratory fitness), assessment of insulin sensitivity&#xD;
      (hyperinsulinemic-euglycemic clamp) and single leg exercise using near-infrared spectroscopy&#xD;
      (microvascular function). Participants will also complete a semi-structured qualitative&#xD;
      interview to understand knowledge and attitudes toward sedentary behavior and questionnaires&#xD;
      to assess the relationship between modifiable psychological and behavioral factors and&#xD;
      sedentary behavior.&#xD;
&#xD;
      The aims of the study are to:&#xD;
&#xD;
        1. Compare objectively-measured, free-living physical activity and sedentary behavior&#xD;
           between older women with and without T2D.&#xD;
&#xD;
        2. Evaluate the relationship between prolonged bouts of sedentary behavior,&#xD;
           cardiorespiratory fitness, glucose control, insulin sensitivity, and skeletal muscle&#xD;
           microvascular function in older women with and without T2D.&#xD;
&#xD;
        3. Assess knowledge and attitudes toward sedentary behavior and characterize the&#xD;
           relationship between knowledge and attitudes toward sedentary behavior and modifiable&#xD;
           psychological and behavioral factors in older women with T2D.&#xD;
&#xD;
        4. Evaluate the relationship between sedentary behavior, mood states, and meaning salience&#xD;
           during &quot;normal&quot; life and the period of confinement imposed by the COVID-19 epidemic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 30, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>time sedentary measured via triaxial accelerometer</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>average sedentary bout length measured via triaxial accelerometer</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiorespiratory fitness</measure>
    <time_frame>8-12 minutes</time_frame>
    <description>peak volume of oxygen consumption (VO2 peak) in ml/kg/min measured via graded exercise test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin sensitivity</measure>
    <time_frame>3 hours</time_frame>
    <description>glucose infusion rate in mg/kg/min as measured via hyperinsulinemic-euglycemic clamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in skeletal muscle deoxygenated hemoglobin concentration during single leg calf exercise measured via near-infrared spectroscopy</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Type 2 Diabetes Mellitus</arm_group_label>
    <description>women age 60-75 years with uncomplicated type 2 diabetes mellitus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>healthy women age 60-75 years</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy women and women with T2D age 60-75 years.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  Age 60-75 years&#xD;
&#xD;
          -  Postmenopausal (self-reported)&#xD;
&#xD;
          -  BMI between 25-40 kg/m2&#xD;
&#xD;
          -  Participants with T2D:&#xD;
&#xD;
          -  T2D confirmed via chart review&#xD;
&#xD;
          -  T2D diet controlled or treated with the following acceptable medication treatments:&#xD;
             metformin, sulfonylureas, glinides, or glucose absorption blockers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  Age &lt;60 or &gt;75 years&#xD;
&#xD;
          -  Type 1 diabetes&#xD;
&#xD;
          -  Control participants only - HbA1C â‰¥ 5.7%&#xD;
&#xD;
          -  Use of beta blockers or centrally-acting calcium channel blockers (i.e., diltiazem,&#xD;
             verapamil) due to potential blunting of cardiorespiratory fitness assessments&#xD;
&#xD;
          -  Use of hormone replacement therapy (e.g., estrogen, progesterone, testosterone)&#xD;
             (within the past 5 years)&#xD;
&#xD;
          -  Taking insulin, thiazolidinediones (e.g., rosiglitazone), glucagon-like peptide-1&#xD;
             (GLP1) agonists (e.g., exenatide), dipeptidyl peptidase-4 (DPP4) inhibitors (e.g.,&#xD;
             sitagliptin) or any medication for the treatment of T2D other than those listed above&#xD;
             in the inclusion criteria&#xD;
&#xD;
          -  Uncontrolled hypertension at rest (systolic &gt;160 or diastolic &gt;110 mmHg)&#xD;
&#xD;
          -  Obstructive pulmonary disease or asthma with a forced expiratory volume in 1 second&#xD;
             (FEV1)/forced vital capacity (FVC) ratio &lt;70% of predicted&#xD;
&#xD;
          -  Any of the following conditions:&#xD;
&#xD;
          -  Uncontrolled T2D (HbA1C &gt;9.0%)&#xD;
&#xD;
          -  Unstable angina&#xD;
&#xD;
          -  Recent myocardial infarction, cardiac surgery, or vascular surgery (&lt;3 months)&#xD;
&#xD;
          -  Heart failure&#xD;
&#xD;
          -  Peripheral artery disease (based on report of symptomatic claudication or ankle&#xD;
             brachial index testing)&#xD;
&#xD;
          -  Anemia (tHb &lt;10 mg/dL)&#xD;
&#xD;
          -  Hepatic or renal disease&#xD;
&#xD;
          -  Severe arthritis or mobility impairment that would interfere with exercise testing&#xD;
&#xD;
          -  Current tobacco or marijuana use or nicotine use within the last year&#xD;
&#xD;
          -  Dementia or evidence of cognitive impairment (Mini-Cog score &lt; 3)&#xD;
&#xD;
          -  Engaging in &gt;150 minutes/week of moderate to vigorous physical activity (assessed via&#xD;
             Low-Level Physical Activity Recall questionnaire)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary O Whipple, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mary O Whipple, PhD</last_name>
    <phone>303-724-2255</phone>
    <email>mary.whipple@cuanschutz.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristina Chapman, BS</last_name>
    <phone>720-848-6690</phone>
    <email>kristina.chapman@cuanschutz.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colorado Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Chapman, BS</last_name>
      <phone>720-848-6690</phone>
      <email>kristina.chapman@cuanschutz.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 6, 2020</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2020</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>sedentary behavior</keyword>
  <keyword>cardiovascular disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

